Skip to main content
Fig. 1 | Annals of General Psychiatry

Fig. 1

From: Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

Fig. 1

An intention-to-treat GEE analysis investigating the effects of vortioxetine (n = 73) versus placebo (n = 74) on the interplay between cognitive function with metabolic disruption, elevated BMI and inflammation in an 8-week trial. The least square (LS) mean (standard error of mean [SEM]) values are depicted for the change in DSST total scores from baseline to endpoint, using an independent covariance matrix with time as a categorical variable

Back to article page

Annals of General Psychiatry

ISSN: 1744-859X